Pushkar M. Kulkarni

566 total citations
13 papers, 466 citations indexed

About

Pushkar M. Kulkarni is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pushkar M. Kulkarni has authored 13 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pushkar M. Kulkarni's work include Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). Pushkar M. Kulkarni is often cited by papers focused on Cannabis and Cannabinoid Research (9 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). Pushkar M. Kulkarni collaborates with scholars based in United States, United Kingdom and Canada. Pushkar M. Kulkarni's co-authors include Ganesh A. Thakur, Roger G. Pertwee, Andrea G. Hohmann, Michael E. Kelly, David R. Janero, Robert B. Laprairie, Richard A. Slivicki, Eileen M. Denovan‐Wright, Ken Mackie and Zhili Xu and has published in prestigious journals such as Biological Psychiatry, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Pushkar M. Kulkarni

13 papers receiving 465 citations

Peers

Countries citing papers authored by Pushkar M. Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Pushkar M. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pushkar M. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pushkar M. Kulkarni more than expected).

Fields of papers citing papers by Pushkar M. Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pushkar M. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pushkar M. Kulkarni. The network helps show where Pushkar M. Kulkarni may publish in the future.

Co-authorship network of co-authors of Pushkar M. Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Pushkar M. Kulkarni. A scholar is included among the top collaborators of Pushkar M. Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pushkar M. Kulkarni. Pushkar M. Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility 2020 ·Bioorganic & Medicinal Chemistry ·(unknown), Pushkar M. Kulkarni, David R. Janero, Ganesh A. Thakur	7
2	Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation 2020 ·Molecules ·(unknown), Elizabeth A. Cairns, Anna-Maria Szczesniak, Pushkar M. Kulkarni, Alex Straiker, Ganesh A. Thakur, Michael E. Kelly	34
3	Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure–Activity Relationship Studies 2019 ·ACS Medicinal Chemistry Letters ·Dow P. Hurst, Sumanta Garai, Pushkar M. Kulkarni, (unknown), Patricia H. Reggio, Ganesh A. Thakur	28
4	The In Vivo Effects of the CB ₁ -Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice 2017 ·Journal of Ocular Pharmacology and Therapeutics ·Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex Straiker, Pushkar M. Kulkarni, Roger G. Pertwee, Ganesh A. Thakur, William H. Baldridge, Michael E. Kelly	25
5	Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence 2017 ·Biological Psychiatry ·Richard A. Slivicki, Zhili Xu, Pushkar M. Kulkarni, Roger G. Pertwee, Ken Mackie, Ganesh A. Thakur, Andrea G. Hohmann	104
6	Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor 2017 ·ACS Chemical Neuroscience ·Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, Michael E. Kelly, David R. Janero, Maria Grazia Cascio, Lesley Stevenson, Roger G. Pertwee, Terrence Kenakin, Eileen M. Denovan‐Wright, Ganesh A. Thakur	86
7	Microwave‐accelerated Conjugate Addition of 2‐Arylindoles to Substituted β‐Nitrostyrenes in the Presence of Ammonium Trifluoroacetate: An Efficient Approach for the Synthesis of a Novel Class of CB1 Cannabinoid Receptor Allosteric Modulators 2017 ·Journal of Heterocyclic Chemistry ·Pushkar M. Kulkarni, (unknown), Sumanta Garai, Ganesh A. Thakur	11
8	Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein–protein interaction inhibitors 2016 ·Behavioural Brain Research ·(unknown), Zhili Xu, Yvonne Y. Lai, Pushkar M. Kulkarni, Ganesh A. Thakur, Andrea G. Hohmann, Jonathon D. Crystal	23
9	Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe 2016 ·ACS Chemical Neuroscience ·Robert B. Laprairie, Abhijit Kulkarni, Pushkar M. Kulkarni, Dow P. Hurst, Diane L. Lynch, Patricia H. Reggio, David R. Janero, Roger G. Pertwee, Lesley Stevenson, Michael E. Kelly, Eileen M. Denovan‐Wright, Ganesh A. Thakur	35
10	Small molecule inhibitors of PSD95-nNOS protein–protein interactions as novel analgesics 2015 ·Neuropharmacology ·Wan-Hung Lee, Zhili Xu, Nicole M. Ashpole, Andy Hudmon, Pushkar M. Kulkarni, Ganesh A. Thakur, Yvonne Y. Lai, Andrea G. Hohmann	56
11	Enantiomer‐Specific Positive Allosteric Modulation of the Type 1 Cannabinoid Receptor 2015 ·The FASEB Journal ·Robert B. Laprairie, Pushkar M. Kulkarni, Maria Grazia Cascio, Roger G. Pertwee, Michael E. Kelly, Eileen M. Denovan‐Wright, Ganesh A. Thakur	1
12	Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s) 2015 ·Journal of Medicinal Chemistry ·Pushkar M. Kulkarni, Abhijit Kulkarni, Anisha Korde, Ritesh Tichkule, Robert B. Laprairie, Eileen M. Denovan‐Wright, Han Zhou, David R. Janero, Nikolai Zvonok, Alexandros Makriyannis, Maria Grazia Cascio, Roger G. Pertwee, Ganesh A. Thakur	53
13	Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. 2015 ·Wan-Hung Lee, Zhili Xu, Nicole M. Ashpole, Andy Hudmon, Pushkar M. Kulkarni, Ganesh A. Thakur, Yvonne Y. Lai, Andrea G. Hohmann	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact